QSAR, ADMET, molecular docking, and dynamics studies of 1,2,4-triazine-3(2H)-one derivatives as tubulin inhibitors for breast cancer therapy

Abstract Breast cancer remains a leading cause of cancer-related deaths among women globally, necessitating the development of more effective therapeutic agents with minimal side effects. This study explores novel 1,2,4-triazine-3(2H)-one derivatives as potential inhibitors of Tubulin, a pivotal pro...

Повний опис

Збережено в:

Бібліографічні деталі
Автори:	Mohamed Moussaoui, Soukayna Baammi, Hatim Soufi, Mouna Baassi, Achraf El Allali, M. E. Belghiti, Rachid Daoud, Said Belaaouad
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Nature Portfolio 2024-07-01
Серія:	Scientific Reports
Предмети:	QSAR Molecular docking ADMET 1,2,4-triazin-3(2H)-one Breast cancer Anticancer
Онлайн доступ:	https://doi.org/10.1038/s41598-024-66877-2
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

QSAR, ADMET, molecular docking, and dynamics studies of 1,2,4-triazine-3(2H)-one derivatives as tubulin inhibitors for breast cancer therapy

Схожі ресурси